Search results for "FAILURE"

showing 10 items of 1977 documents

Evaluation of a novel biomarker of type XXVIII collagen formation, PRO-C28, in samples from cancer and heart failure with preserved ejection fraction…

2020

Increased turnover of extracellular matrix proteins is seen in many different diseases and is an underlying and driving feature of pathogenesis. An increased ratio of formation over degradation of extracellular matrix proteins, such as collagens, leads to accumulation of proteins in the tissues, ultimately impairing organ function. Understanding how this balance is regulated is key to providing deeper insight into high extracellular matrix turnover diseases. Type XXVIII collagen is a novel collagen with limited information available in relation to expression, tissue prevalence and clinical implication. We generated a novel, technically robust ELISA to measure a C-terminal fragment of type X…

Heart Failuremedicine.medical_specialtyChemistryClinical BiochemistryPharmaceutical ScienceCancerStroke Volumemedicine.diseasePeptide FragmentsAnalytical ChemistryPathogenesisExtracellular matrixCollagen formationEndocrinologyInternal medicineNeoplasmsDrug DiscoverymedicineBiomarker (medicine)HumansIn patientLung cancerHeart failure with preserved ejection fractionSpectroscopyBiomarkersJournal of pharmaceutical and biomedical analysis
researchProduct

Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review.

2021

Congestion explains many of the signs and symptoms of acute heart failure (AHF) and disease progression. However, accurate quantification of congestion is challenging in daily practice. Antigen carbohydrate 125 (CA125) or mucin 16 (MUC16), a large glycoprotein synthesized by mesothelial cells, has emerged as a reliable proxy of congestion and inflammation in patients with heart failure. In AHF syndromes, CA125 is strongly associated with right-sided heart failure parameters and a higher risk of adverse clinical events beyond standard prognostic factors, including natriuretic peptides. Furthermore, CA125 has the potential for both monitoring and guide HF treatment following a decompensated H…

Heart Failuremedicine.medical_specialtyClinical eventsbusiness.industryDisease progressionCarbohydratesSigns and symptomsmedicine.diseasePrognosisAntigenHeart failureCA-125 AntigenmedicineDisease ProgressionBiomarker (medicine)HumansNarrative reviewIn patientCardiology and Cardiovascular MedicineIntensive care medicinebusinessBiomarkersEuropean journal of heart failureReferences
researchProduct

Beyond left ventricular ejection fraction there is a right heart that pumps.

2017

Heart Failuremedicine.medical_specialtyEjection fractionVentricular functionbusiness.industryHeartStroke VolumeStroke volume030204 cardiovascular system & hematologymedicine.diseaseVentricular Function Left03 medical and health sciencesVentricular Dysfunction Left0302 clinical medicineHeart failureInternal medicineRight heartCardiologyMedicineHumans030212 general & internal medicineCardiology and Cardiovascular MedicinebusinessEuropean journal of heart failure
researchProduct

Cardiorenal Syndrome in Acute Heart Failure: Revisiting Paradigms

2015

A B S T R A C T Cardiorenal syndrome has been defined as the simultaneous dysfunction of both the heart and the kidney. Worsening renal function that occurs in patients with acute heart failure has been classified as cardiorenal syndrome type 1. In this setting, worsening renal function is a common finding and is due to complex, multifactorial, and not fully understood processes involving hemodynamic (renal arterial hypoperfusion and renal venous congestion) and nonhemodynamic factors. Traditionally, worsening renal function has been associated with worse outcomes, but recent findings have revealed mixed and heterogeneous results, perhaps suggesting that the same phenotype represents a dive…

Heart Failuremedicine.medical_specialtyKidneyCardio-Renal Syndromebusiness.industryHemodynamicsHemodynamicsRenal functionGeneral MedicineCardiorenal syndromeurologic and male genital diseasesmedicine.diseasePathophysiologymedicine.anatomical_structureHeart failureAcute DiseasemedicineHumansDecompensationIntensive care medicinebusinessPerfusionRevista Española de Cardiología (English Edition)
researchProduct

Chronotropic Incompetence Predicts Distance Walked in Six-Minute Walk Test in Heart Failure With Preserved Ejection Fraction

2020

Heart Failuremedicine.medical_specialtySIX MINUTE WALKExercise Tolerancebusiness.industryChronotropic incompetenceStroke VolumeWalk TestWalkingTest (assessment)Heart RateInternal medicineExercise TestmedicineCardiologyHumansCardiology and Cardiovascular MedicineHeart failure with preserved ejection fractionbusinessJournal of Cardiac Failure
researchProduct

Diuretic Treatment in Heart Failure.

2018

Heart Failuremedicine.medical_specialtySettore MED/09 - Medicina Internabusiness.industryDiuretic heart failureTreatment outcomeMEDLINEGeneral Medicine030204 cardiovascular system & hematologymedicine.diseaseDiuretic treatment03 medical and health sciences0302 clinical medicineText miningTreatment OutcomeHeart failureMedicineHumans030212 general & internal medicinebusinessIntensive care medicineDiureticsThe New England journal of medicine
researchProduct

Urine: an overlooked biomedium in heart failure?

2020

Heart Failuremedicine.medical_specialtyUrinary sodiumbusiness.industryBiochemistry (medical)Clinical BiochemistrySodiumUrologyMEDLINEUrineAcute Kidney Injurymedicine.diseaseUrine biomarkersHeart failureDrug DiscoverymedicineAlbuminuriaHumansmedicine.symptombusinessBiomarkersBiomarkers in medicine
researchProduct

Prognostic implications of pericardial effusion: The importance of underlying etiology

2015

Heart Failuremedicine.medical_specialtybusiness.industry030204 cardiovascular system & hematologyPrognosismedicine.diseasePericardial effusionPericardial Effusion03 medical and health sciences0302 clinical medicineHeart failureInternal medicinemedicineCardiologyEtiologyHumans030212 general & internal medicineCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct

Statins in Heart Failure

2015

Heart Failuremedicine.medical_specialtybusiness.industryMEDLINEGeneral Medicine030204 cardiovascular system & hematologymedicine.disease03 medical and health sciencesHydroxymethylglutaryl-CoA Reductase Inhibitors0302 clinical medicineHeart failureInternal medicinemedicineCardiologyHumans030212 general & internal medicineHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessRevista Española de Cardiología (English Edition)
researchProduct

Heart failure risk reduction:hydrophilic or lipophilic statins?

2020

[No abstract]

Heart Failuremedicine.medical_specialtybusiness.industryMEDLINEmedicine.diseaseReduction (complexity)Text miningInternal medicineHeart failuremedicineCardiologyHumansPharmacology (medical)Hydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessHydrophobic and Hydrophilic InteractionsRisk Reduction Behavior
researchProduct